Providence Neurological Specialties

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Multiple sclerosis2 trials

Phase

• Phase 31 trial

Status

• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• EMD Serono Research & Development Institute, Inc.1 trial
• Hoffmann-La Roche1 trial

Running trials

• Active, not recruiting

  A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis

  NCT05269004· Phase 3· Hoffmann-La Roche· Source

Closed trials

• Completed

  A Study of Suboptimally Controlled Participants Previously Taking Oral or Infusion DMDs for RMS (MASTER-2)

  NCT03933202· EMD Serono Research & Development Institute, Inc.· Source